Demographic and Clinical Characteristics Associated with Minimally Invasive Glaucoma Surgery Use: An Intelligent Research in Sight (IRIS®) Registry Retrospective Cohort Analysis.
Olivier Mildred M G, Smith Oluwatosin U, Croteau-Chonka Clarisse C, VanderBeek Brian L, Maguire Maureen G, Lum Flora, Fujino Danielle, Kelly Scott P, Rich William L, Miller-Ellis Eydie G
AI Summary
This study found MIGS use during cataract surgery varied by age, race, insurance, region, and glaucoma severity, suggesting diverse patient selection patterns.
Abstract
Purpose
Minimally invasive glaucoma surgery (MIGS) is increasingly performed at the time of cataract extraction. Understanding the demographic and clinical characteristics of patients undergoing MIGS procedures may provide insight into patient selection. This study evaluates racial-ethnic and other differences in the use of MIGS in persons with cataract and open-angle glaucoma (OAG).
Design
Retrospective cohort study using Intelligent Research in Sight (IRIS) Registry data.
Participants
Patients aged ≥ 40 years with a diagnosis of OAG and no history of MIGS or cataract surgery who were undergoing cataract extraction, with or without MIGS, during 2013 to 2017 in the United States.
Methods
Multivariable logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).
Main outcome measures
Variables assessed include age, sex, race-ethnicity, disease severity, insurance type, census region, comorbidity, and cup-to-disc ratio (CDR).
Results
The odds of MIGS use was greater among patients who were aged ≥ 60 years (OR, 1.10 [95% CI, 1.05-1.16]); Black (OR, 1.11 [CI, 1.07-1.15]) compared with White; a Medicare recipient (OR, 1.12 [CI, 1.10-1.15]) versus privately insured; or in the Midwest (OR, 1.32 [CI, 1.28-1.36]) or Northeast (OR, 1.26 [CI, 1.22-1.30]) compared with the South. Having moderate rather than mild glaucoma (OR, 1.07 [CI, 1.04-1.11]) and a higher CDR (OR for 0.5 to 0.8 vs. <0.5, 1.24 [CI, 1.21-1.26]; OR for >0.8 to 1.0 vs. <0.5, 1.27 [CI, 1.23-1.32]) were also each associated with increased odds of MIGS use. Use of MIGS was less likely in women (OR, 0.96 [CI, 0.94-0.98]); patients taking 5 to 7 glaucoma medications (OR, 0.94 [CI, 0.90-0.99]) compared with 1 to 2 medications; and patients with severe, compared with mild, glaucoma (OR, 0.64 [CI, 0.61-0.67]).
Conclusions
This analysis highlights the importance of capturing race-ethnicity data and other pertinent patient characteristics in electronic health records to provide insight into practice patterns. Such data can be used to assess the long-term performance of MIGS and other procedures in various patient populations.
MeSH Terms
Shields Classification
Key Concepts6
The odds of minimally invasive glaucoma surgery (MIGS) use was greater among patients aged ≥ 60 years (OR, 1.10 [95% CI, 1.05-1.16]) compared to younger patients.
Black patients had a greater odds of minimally invasive glaucoma surgery (MIGS) use (OR, 1.11 [CI, 1.07-1.15]) compared with White patients.
Medicare recipients had a greater odds of minimally invasive glaucoma surgery (MIGS) use (OR, 1.12 [CI, 1.10-1.15]) compared to privately insured patients.
Patients in the Midwest (OR, 1.32 [CI, 1.28-1.36]) or Northeast (OR, 1.26 [CI, 1.22-1.30]) had greater odds of minimally invasive glaucoma surgery (MIGS) use compared with patients in the South.
Having moderate rather than mild glaucoma (OR, 1.07 [CI, 1.04-1.11]) and a higher cup-to-disc ratio (CDR) (OR for 0.5 to 0.8 vs. <0.5, 1.24 [CI, 1.21-1.26]; OR for >0.8 to 1.0 vs. <0.5, 1.27 [CI, 1.23-1.32]) were associated with increased odds of minimally invasive glaucoma surgery (MIGS) use.
Use of minimally invasive glaucoma surgery (MIGS) was less likely in women (OR, 0.96 [CI, 0.94-0.98]), patients taking 5 to 7 glaucoma medications (OR, 0.94 [CI, 0.90-0.99]) compared with 1 to 2 medications, and patients with severe, compared with mild, glaucoma (OR, 0.64 [CI, 0.61-0.67]).
Related Articles5
Geographic Distribution of Access to Glaucoma Surgery: An IRIS® Registry (Intelligent Research in Sight) Analysis.
Cohort StudyThe incidence of serious complications after selective laser trabeculoplasty.
Cohort StudyImpact of the COVID-19 pandemic on glaucoma surgery in German hospitals.
Observational StudyComparing Traditional and Newer Glaucoma Procedures by Physician Experience and Practice Location in the United States.
Cross-Sectional StudyEffect of COVID-19 pandemic on glaucoma surgical practices in the UK.
Cross-Sectional StudyIs this article assigned to the wrong chapter(s)? Let us know.